Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of XPLR Infrastructure, LP (formerly Nextera Energy Partners, LP), encouraging them to contact the firm regarding potential lead plaintiff appointments in a class action lawsuit due to alleged misleading statements and operational struggles during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from September 27, 2023, to January 27, 2025 [3]. - Allegations include that XPLR was struggling to maintain operations as a yieldco, and that the defendants issued materially false and misleading statements while downplaying risks associated with financing arrangements [3]. - It is claimed that XPLR could not resolve financing issues before maturity without risking significant unitholder dilution, leading to a planned halt in cash distributions to investors [3]. - The sustainability of XPLR's yieldco business model and distribution growth rate is questioned, with assertions that public statements made by the defendants were materially false and misleading [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by September 8, 2025, to participate in the case without any cost or obligation [4]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that artificially inflated stock prices [5].

Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities during the specified Class Period [1][2]. Company Overview - RxSight, headquartered in Aliso Viejo, CA, is a medical technology company that develops light adjustable intraocular lenses (LAL) used in cataract surgery [2]. Legal Allegations - The lawsuit alleges that RxSight failed to disclose significant issues, including: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3]. 2. Overstated demand for RxSight's products [3]. 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3]. Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance. CEO Ronald Kurtz attributed the decline to adoption challenges [4]. - Following this announcement, RxSight shares fell by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4].

NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. T ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of XPLR Infrastructure, LP (formerly Nextera Energy Partners, LP), encouraging them to contact the firm regarding potential lead plaintiff appointments in a class action lawsuit due to alleged misleading statements and operational struggles during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from September 27, 2023, to January 27, 2025 [3]. - Allegations include that XPLR was struggling to maintain operations as a yieldco and that the defendants issued materially false and misleading statements while downplaying risks associated with certain financing arrangements [3]. - It is claimed that XPLR could not resolve financing issues before maturity without risking significant unitholder dilution, leading to a planned halt in cash distributions to investors [3]. - The sustainability of XPLR's yieldco business model and distribution growth rate is questioned, with assertions that public statements made by the defendants were misleading throughout the relevant period [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by September 8, 2025, to participate in the case without any cost or obligation [4]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's status [4]. Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors affected by deceit and illegal business practices, emphasizing the importance of responsible corporate behavior [5].

Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities during the specified class period [1][2]. Company Overview - RxSight, Inc. is a medical technology company based in Aliso Viejo, CA, specializing in light adjustable intraocular lenses (LAL) used in cataract surgery, with its system involving the Light Delivery Device (LDD) [2]. Legal Allegations - The lawsuit alleges that RxSight's management failed to disclose significant issues, including: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3]. 2. Overstated demand for RxSight's products [3]. 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3]. Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance. CEO Ronald Kurtz attributed the sales stall to adoption challenges over recent quarters [4]. - Following this announcement, RxSight shares fell by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fortrea Holdings Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its financial prospects and business model during the specified class period [1][2]. Group 1: Allegations - The complaint alleges that Fortrea overestimated the revenue contributions from its long-term projects, known as the Pre-Spin Projects, to its 2025 earnings [1]. - It is claimed that Fortrea overstated the cost savings expected from exiting transition services agreements [1]. - The company's previously announced EBITDA targets for 2025 were allegedly inflated due to these misrepresentations [1]. - The viability of Fortrea's post-spin-off business model and its financial prospects were reportedly overstated [1]. - Consequently, the company's public statements were materially false and misleading throughout the relevant period [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as July 3, 2023, to February 28, 2025 [1]. - Shareholders are encouraged to register for the class action by the deadline of August 1, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Schall Law Firm is investigating Proficient Auto Logistics, Inc. for potential violations of securities laws related to misleading statements and undisclosed information affecting investors [1][2]. Group 1: Investigation Details - The investigation centers on whether Proficient Auto issued false or misleading statements and failed to disclose relevant information to investors [2]. - Following the announcement of Q1 financial results on May 7, 2025, Proficient Auto reported a decline in year-over-year total operating revenue and a net operating loss [2]. - As a result of the negative financial news, Proficient Auto's shares fell by more than 4.9% the following day [2]. Group 2: Legal Representation - The Schall Law Firm offers free consultations for shareholders who may have suffered losses due to the company's actions [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations related to the proposed acquisition of Veritex Holdings, Inc. by Huntington Bancshares Incorporated, which is valued at approximately $1.9 billion [1]. Group 1: Acquisition Details - The proposed acquisition involves stockholders of Veritex Holdings receiving 1.95 shares of Huntington Bancshares common stock for each share of Veritex Holdings stock they hold [1]. - The transaction is expected to close in the fourth quarter of 2025 [1]. Group 2: Legal Investigation - Rowley Law PLLC is representing shareholders in the investigation concerning the acquisition and potential securities law violations by Veritex Holdings and its board of directors [1]. - Additional information regarding the investigation can be obtained by contacting Rowley Law PLLC [2].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit related to misleading statements and omissions concerning the safety of its Enfamil formula for preterm infants [1][3]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 13, 2021, to July 28, 2024 [3]. - Allegations include that Reckitt's cow's milk-based formula, Enfamil, posed an increased risk of necrotizing enterocolitis (NEC) in preterm infants, which was not disclosed [3]. - The lawsuit claims that Reckitt's positive statements about its business and operations were materially false and misleading due to the undisclosed risks and potential legal claims [3]. Group 2: Shareholder Actions and Deadlines - Shareholders are encouraged to register for the class action by August 4, 2025, to participate in potential recovery [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit and illegal business practices [5]. - The firm emphasizes the importance of responsible business practices and corporate citizenship [5]. - The firm seeks recovery for investors affected by misleading statements that led to artificial inflation of the company's stock [5].

Core Viewpoint - Berger Montague is investigating potential securities law violations involving Petco Health and Wellness Company, Inc., following a class action lawsuit filed on behalf of investors who acquired Petco securities between January 14, 2021, and June 5, 2025 [1][2] Group 1: Legal Investigation - A class action lawsuit has been initiated against Petco, with a deadline for investors to seek lead plaintiff status by August 29, 2025 [2] - The lawsuit alleges that Petco made materially false and misleading statements regarding its pandemic-related growth and the sustainability of its premium pet food business model [3] Group 2: Financial Impact - The complaint claims that these misrepresentations led to significant declines in Petco's stock price, including a drop of over 20% on August 24, 2023, following a downward revision of financial guidance [3]